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1. Introduction: Human Genome Project
  Now we are in the beginning of the twenty-first century. What is one of the 
most controversial issues in law and society in countries all over the world in this 
new century? lt may not be an exaggeration to say that the issues over genetic
Koichi SETOYAMA, Lecturer and Foreign Student Advisor at the Graduate School of Law and 
Faculty of Law, Osaka University. M.L.I., LL.M., S.J.D. Dissertator at the University of 
Wisconsin Law School, U.S.A. 
  This paper is a part of my LL.M. thesis submitted to the University of Wisconsin Law School 
U.S.A. in summer 2002, in partial fulfillment of the requirement for the degree of Master of 
Laws. Although the original thesis has been modified to some extent, in general the content is not 
revised nor updated at this time. 
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technology and the human genome are definitely one of them. In the USA, it is 
offen stated that "[d]iscoveries of genetic information could be the civil rights battle 
of the next [21st] century."l)
  The scientific implantation of genetic issues dates back to about a half century 
ago. In 1953, James Watson and Francis Crick discovered the double helix 
structure of DNA (Deoxyribonucleic Acid), the basic building block of life.2) Now, 
it is widely known that the genome is the pattern of DNA that codes for proteins 
and physical processes.3) Our hereditary information is transmitted from generation 
to generation by molecules of DNA 4). According to a report, genetic disease is 
responsible for 20% of infant death and is the leading cause of death in the 1-to-4 
year old age group and genetic disorders account for 25-30% of acute care hospital 
admissions of persons under 18 and about 13% of adult admission.5) Scientists are 
increasingly learning what people seldom think of as genetic-conditions as diverse 
as cancer, heart disease, schizophrenia, and alcoholism.() And the rapid 
development of biotechnology and the human genome, and strong social awareness 
about the implications of elucidating the human genome have been initiated since 
the Human Genome Project (HGP) was launched in October 1990. It is an 
international collaboration research effort in which nearly 20 countries are involved 
in order to map the genes an the twenty-three human chromosomes that are made
1)
2)
3)
4)
5)
6)
This is a phrase which is quoted as an introductory epigraph in his Note by Burk Burnett. Burk 
Burnett, Note, Genetic Discrimination: Legislation Required to Keep Genetic Secrets, 21 SETON 
HALL LEGIS. J. 502 (1997); the original Statement made by Rep. Cliff Stearns, 142 Cong. Rec. 
H2845 (daily ed. Mar.26, 1996). 
James Watson and Francis Crick, Molecular Structure of Nucleic Acids: A Structure for 
Deoxyribose Nucleic Acid, 171 NATURE 737 (1953); James Watson, DOUBLE HELIx: A PERSONAL 
ACCOUNT OF THE DISCOVERY OF DNA (1968). 
See Sonia M. Suter, Note: Whose Genes Are These Anyway? : Familial Conflicts over Access to 
Genetic Information, 91 MICH. L. REV. 1854 n3 (1993). 
The structure of DNA consists of two long Strands coiled around one another to form a double 
helix. Variability within the molecule is provided by four different bases: adenine (A), guanine 
(G), thymine (T), and cytosine (C). See REPRODUCTIVE G NETICS AND THE LAW 1 (George J. Annas 
& Sherman Elias eds., Year Book Medical Publishers, Inc. 1987). 
CASES AND MATERIALS ON LAW AND MEDICINE 803-04 (Walter Wadlington et al., 1980) (relying an 
U.S. DEPARTMENT OF HEW, PUBLIC HEALTH SERVICE, NATIONAL INSTITUTES OF HEALTH DRAFT, 
CONSENSUS DEVELOPMENT CONFERENCE ON ANTENATAL DIAGNOSIS, TASK FORCE REPORT: PREDICTORS 
OF HEREDITARY DISEASE OR CONGENITAL DEFECTS (1979)). 
Lori A. Whittaker, The Implications of the Human Genome Project.for Family Practice, 35 J. 
FAM. PRAG 294 (1992).
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up of our DNA and determine the location of all human genes.? The U.S. Congress 
funded the Human Genome Project $3,000,000,000, tomap and sequence the entire 
human genome.8 The main goal of the project was to identify all the 
approximately 30,000-35,000 genes in the human DNA and identify the genetic 
disorders which cause diseases and eventually prevent or cure such genetic 
diseases.9) The project was originally planned to complete its task in 2005. 
However, rapid technological advances have accelerated its speed in mapping the 
genetic sequences. lt is not far from our memory that in June 2000, former 
President Clinton announced that the International Human Genome Project and 
Celera Genomics Corporation have completed an initial sequencing of the human 
genome (the genetic blueprint for human beings).10) And an February 12, 2001, the 
international HGP public consortium announced the publication of a draft sequence 
which covers more than 90 percent of the human genome-the genetic blueprint for 
a human being and the result of initial analysis, the content of which appeared in 
the February 15 issue of the journal NATURE." And an April 14th, 2003, exactly in 
the 50th year anniversary of the discovery of the DNA double helix, the sequencing 
of the human genome was completed12). lt was two years earlier than the originally 
planned schedule.
II. Legal Issues Over the Availability of Genetic Information
  With the beginning of the twenty-first century, the frontier of biotechnology and 
our world has literally entered into the new genetic era. While findings of the
7)
s)
9)
For details of the Human Genome Project, see < http://www.ornl.gov/hgmis/>; <http:// 
www.nhgri.nih.gov/About_NHGRI/>; Oak Ridge National Laboratories, Human Genome Project 
Information, Frequently Asked Questions, available at http://www.ornl.gov/hgmis/faq/fagsl.html 
(last modified Feb. 15, 2002). 
Funding for the Project began in 1990 and it was completed in2003. See James D. Watson, The 
Human Genome Project: Past, Present, and Future, 248 SCIENCE 44 (1990). 
Sonia M. Suter, Note: Whose Genes Are These Anyway? : Familial Conflicts over Access to 
Genetic Information, 91 MICH. L. REV. 1854 (1993).
10) The White House Office of the Press Secretary, President Clinton Announces the Completion of
the First Survey of the Entire Human Genome, June 25, 2000. Available at <http://www.ornl.gov/ 
hgmis/project/clinton1/htm> (last visited July 1, 2002).
11) <http://www.ornl.gov/hgmis/project/feb_pr/summary_of sequence.html> (last visited July 1, 2002);
  <http://www.ornl.gov/hgmis/project/feb_pr/initial sequencePR.html> (last visited July 1, 2002); 
  <http://www.oml.gov/hgmis/project/feb_pr/physical map.html> (last visited July 1, 2002). 
12) <http://www.ornl.gov/sci/techresources/Human Genome/project/timeline.shtml> (last visited 
  December 21, 2004).
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Human Genome Project brings about tremendous medical benefits such as the 
possibility of genetic therapy and prevention of human diseases caused by the 
defects of DNA, an the other hand, it also raises serious social problems such as 
genetic discrimination in employment and insurance, etc. The new advancement of
genetic technology removes the "weil of ignorance" concerning the individual's 
future illness and life span. The Human Genome Project has already opened the 
door of Pandora's Box of the genetic secret. Inside the unlocked box, there is a 
"Book of Life
," the most fundamental biological information of the human being 
and we can neither lock the door any Tonger nor go back to the past. It poses new 
privacy concerns and discriminations in a variety of social settings. Science-fiction 
motion picture thriller "Gattaca"13) directed by Andrew Nicole describes the 
possible future world where people are judged by their genes, and the main 
character Vincent is classified as a genetic underclass citizen an birth and he 
"struggle[s] to achieve his life's goal of space travel in the face of legal and social 
barriers."14) In the real world, our science already has a technology known as 
Polymerase Chain Reaction (PCR) which can amplify enough DNA from even the 
back of a stamp.15) If we got a hair or saliva of a person and asked an institution
13) Columbia Tri-Star 1997. For descriptions and discussion of the issues explored in the film, see 
   Bob Kurson, Dabbling in DNA: "Gattaca " Director Exploring Ethics, Chi. Sun-Times, Nov. 16, 
   1997, at 7-NC, available in 1997 WL 6379554; Kathi Wolfe, Genetic Engineering: Two Sides of 
   the Coin, LAS VEGAS REV.-J., Nov. 28, 1997, at 15B, available in 1997 WL 4558846; Roger 
   Ebert, Future Tense: "Gattaca" Sees Flaws in a Perfect World, CHI. SUN-TIMES, Oct. 24, 
   1997, at 35, available in 1997 WL 6375250; Rene Downing, 'Gattaca' Premise: Future's Not in 
   Stars, but in Our Genes, ARIZ. DAILY STAR, Nov. 20, 1997, at 1C, available in 1997 WL
   7934923. "Gattaca, whose title is comprised of the letters G, T, C, and A, which represents the 
  four nitrogenous bases making up deoxyribonucleic acid (DNA), is a 'vision of a possible high-
   tech-militarized-corporate future' with elements of Aldous Huxley's 'social-control dystopia,' 
   Brave New World." See, id. 
14) Peter H. W. van der Goes, Jr., Comment, Opportunity Lost: Why and How to Improve the HHS-
   Proposed Legislation Governing Law Enforcement Access to Medical Records, 147 U. PA. L. 
  REV. 1009, 1010 n5 (1999). 
15) Thomas H. Murray, Genetic Exceptionalism and "Future Diary". Is Genetic Information 
   Different from Other Medical Information?, in GENETIC SECRETS: PROTECTINGPRIVACY AND 
   CONFIDENTIALITY IN THE GENETIC ERA 60, 60 (Mark A. Rothstein ed., Yale Univ. Press 1997) 
   (giving an episode that the FBI investigation laboratories had conducted analysis of samples 
   connected to the bombing in 1993 of the former World Trade Center in Manhattan and they had 
   an envelope in which an incriminating document had been sent. By using the polymerase chain 
  reaction technique, they amplified enough DNA from the back of the stamp to link it with one of 
   the chief suspects through a genetic fingerprint and found that someone else had licked the 
   envelope itself.)
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which has the technique to decode genetic information to test genetic diseases, we 
could find out the genetic fingerprint of that person. The possibility of misusing 
genetic information for non-medical purposes tremendously increases. Therefore, it 
seems urgent o ban genetic tests without informed consent by law and protect he 
genetic privacy of individuals in order to guarantee that genetic information will be 
used to maximize the medical benefits such as diagnosis, prevention and treatment 
of diseases, etc., and not used to discriminate or stigmatize against genetically 
unlucky persons or groups. This genetic technology raises many new unexpected 
social, ethical and legal issues. Responding to these concerns, the U.S. Department 
of Energy (DOE) and the National Institutes of Health (NIH) have "devoted 3% to 
5% of their annual Human Genome budgets toward studying the ethical, legal, and 
social issues (ELSI) surrounding the availability of genetic information."16) 
  All that we can possibly do after having unlocked the door of Pandora's Box is 
to minimize the unintended adverse consequences of the HGP. Legal professionals 
are facing many new legal issues posed by new genetic technology and the 
completion of the HGP, for example, reproductive genetics uch as preconception 
genetic testing, prenatal diagnosis and selective abortion; patent issues over the new 
findings of DNA products and diseases, and the like. Genetic information and 
technology may also be used by a variety of entities in the many legal settings for 
nonmedical purposes: in insurance (in the underwriting process, setting premiums, 
coverage, etc.); in employment (in the decisions of hiring, promotion, fringe 
benefits, etc.); in commercial transactions (loans, mortgage, credit cards, etc.); in 
forensics or criminal justice (identification of dead bodies of the victims in criminal 
settings or in the war, investigating criminal suspects, using defendant's genotype 
as a defense or in parole hearings, etc.); in litigation (determination i parentage or 
heirship, medical malpractice, and other causes of action based an genetic 
medicine, proof of causation in personal injury cases, in assessing compensatory 
damages, child custody disputes, adoption proceedings, etc.); in education or school 
(especially professional schools such as medical or law schools, etc.). 17)
16) Human Genome Project Info., Ethical, Legal, and Social Issues (ELSI) of the Human Genome 
   Project, at http://www.oml.gov/hgmis/elsi/elsi.html (last visited July 2, 2002). 
17) For an overview of these legal issues regarding the nonmedical uses of genetic information, see, 
   e.g., Mark A. Rothstein, The Use of Genetic Information for Nonmedical Purposes, 9 J.L. & 
   HEALTH 109 (1994-1995) (classifying nonmedical uses of genetic information into eight 
   categories: (1) identification, (2) employment, (3) insurance, (4) commercial transactions, (5) 
   domestic relations, (6) education, (7) criminal justice, and (8) tort litigation.); also see MarkA. 
   Rothstein, Recommendations: Genetic Secrets: A Policy Framework, in GENETIC SECRETS: 
   PROTECTING PRIVACY AND CONFIDENTIALITY IN HE GENETIC ERA 451 (Mark A. Rothstein ed., Yale 
   Univ. Press 1997) and their accompanying texts.
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  Genetic discrimination has occurred and will occur in the variety of fields in the 
above-enumerated list. However, discussing each of the genetic discrimination 
issues is beyond the scope of this thesis. As a preliminary examination to discuss 
the genetic discrimination issues, in this paper 1 will clarify the meaning of genetic 
privacy which is the central concept for protection in the issues of genetic 
discrimination. 1 will identify the meaning and scope of genetic privacy by 
referring to the observations made by scholars and the model Genetic Privacy Act 
of 1995. Also 1 will identify the competing interests that need to be balanced in 
formulating a comprehensive genetic privacy protection policy; an one hand, the 
individuals' interests uch as protection of individuals' social and economic well-
being, the individuals' psychological interests, relational (family) interests, and 
autonomy, while an the other hand, social interests such as the promotion of 
scientific research, public health or safety, and economic efficiency. The main 
purpose of this paper is to demonstrate what kind of genetic privacy is put in danger 
by genetic discrimination and to delineate the compelling reasons why genetic 
discrimination should be legally banned. 1 will explain how genetic discrimination 
undermines not only genetic privacy but also the goal of the Human Genome 
Project, and public benefits and social interests. In order to explore an appropriate 
legal policy for genetic discrimination issues, it seems indispensable to identify the 
nature and the unique characteristics of genetic information. Before discussing this 
issue, the meaning of genetic privacy will be examined in the following sections.
III. Genetic Privacy
  When we explore genetic discrimination issues, genetic privacy is the key 
concept because the interests at stake to be protected from genetic discrimination 
are derived from this concept. 1 will clarify the meaning and scope of genetic 
privacy and also refer to the model Genetic Privacy Act of 1995. The concept of 
"privacy" is a huge concept and has many meanings. There has been a great 
number of scholarly works and explanations about "privacy" in American legal 
theory and the jurisprudence of the courts but 1 will not review them in this paper, 
since it is beyond the scope of this thesis. Rather, for the purpose of this paper, it is 
beneficial to identify the meaning of "genetic privacy" in the light of genetic 
discrimination.
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A. Four Dimensions of Genetic Privacy
  Anita L. Allen identifies the meanings of genetic privacy. Allen observes that 
"[w]hen used to label issues that arise in contemporary bioethics and public policy
, 
`privacy' generally refers to one of four categories of concern."18) Allen describes 
current patterns of linguistic usage of genetic privacy by categorizing them into (1) 
informational privacy; (2) physical privacy; (3) decisional privacy; and (4) 
proprietary privacy. 19) 
  (1) Informational privacy includes the concept of confidentiality, secrecy, 
anonymity and fair information practice and mainly "concerns about access to 
personal information."20) She states that "[s]ubstantial limits an third-party access 
to confidential, anonymous, or secret genetic information are requirements of 
respect for informational privacy."21) Mark A. Rothstein also notes that "[t]he 
essence of informational privacy is controlling access to personal information."22 
When we discuss about genetic discrimination, the typical third party is insurance 
companies or employers. 
  (2) Physical privacy is the dimension of "concerns about access to persons and 
personal spaces."23) It is "at issue in relation to population [genetic] screening or 
the [genetic] testing of adults without informed consent."24) It "underlies concerns 
about genetic testing, screening, or treatment without voluntary and informed 
consent."25) In other words, it is related to "issues of bodily integrity surrounding 
genetic testing."26) 
  (3) Decisional privacy is the category that refers to "concerns about 
governmental nd other third-party interference with personal choices."27) It is the 
dimension which is related to "issues of the right to make autonomous health
18) Anita L. Allen, Genetic Privacy: Emerging Concepts and Values, in GENETIC SECRETS: PROTECTING 
   PRIVACY AND CONFIDENTIALITY IN THE GENETIC ERA 33 (Mark A. Rothstein ed., Yale Univ. Press 
  1997). 
19) Id. at 41-47. 
20) Id. at 33. 
21) Id. 
22) Mark A. Rothstein, Genetic Secret: A Policy Framework, in GENETIC SECRETS: PROTECTING 
   PRIVACY AND CONFIDENTIALITY IN THE GENETIC ERA 453 (Mark A. Rothstein ed., Yale Univ. Press 
  1997). 
23) Allen, supra note 18, at 33. 
24) Id. at 46. 
25) Id. at 34. 
26) Rothstein, Recommendations: Genetic Secret: A Policy Framework, at 453. 
27) Allen, supra note 18, at 33.
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choices based an genetic information."28) Allen states that "[a] degree of choice 
with regards to genetic ounseling, testing, and abortion are requirements of respect 
for decisional privacy."29) 
  (4) Proprietary privacy is the class of "concerns about he appropriation a d 
ownership of interests in human personality."30) lt "encompasses is ues relating to 
the appropriation f individuals' possessory and economic interests in their genes 
and other putative bodily repositories of personality."31) 
  Informational privacy is the main privacy interest which is infringed by genetic 
discrimination because insurers' and employers' access to genetic information is
the very issue at stake in genetic discrimination. However, the scope of genetic 
privacy is not limited to this category. When insurance companies require genetic 
testing as a condition to obtain insurance policy or employers equest genetic tests 
as a condition for final job offer and screening employees, physical privacy is_also 
threatened. 
  Decisional privacy is also a very important genetic privacy interest which is 
exposed to danger by genetic discrimination. The crucial personal decision of 
whether to undergo genetic tests or not itself is a very important aspect of 
decisional privacy. The right not to know one's own genetic information should be 
protected. For example, if there is no medical technique to eure a specific genetic 
disease, such as Huntington's disease, some people may not want to know their 
future fate and short life span. 32) However, if insurance companies and employers 
are allowed to request genetic tests as a condition of insurability or employment, 
decisional privacy is likely to be threatened because it infringes and denies the right 
not to know one's ultimate personal information and undermines one's decision ot 
to take genetic tests. Furthermore, aswill be discussed later, because of the nature 
of genetic information, taking genetic tests sometimes reveals that other blood 
family members also have a high possibility of being affected by the same genetic 
disorder as the person who took the genetic tests. Therefore, forcing genetic tests 
as a requirement of insurability or employment may not only infringe the right not
28) Id. 
29) Id. at 34. 
30) Id. at 33. 
31) Id. 
32) The Suicide rate is four times greater among patients diagnosed with Huntington's disease than 
   among the corresponding American Caucasian population. See Lindsay A. Farrer, Suicideand 
   Attenzpted Suicide in Huntington Disease: Implications.for Preclinical Testing of Persons at Risk, 
   24 AM. J. MED. GENETICS 305, 305-11 (1986).
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to know the genetic misfortune of the person who took genetic tests but also some 
of his or her family members' right not to know. 
  Moreover, if there is no legal protection to prevent genetic discrimination, for 
fear of losing health insurance or being unable to obtain insurance or employment, 
the people are hesitant and reluctant to undergo genetic tests which are extremely 
beneficial to early detection of their genetic disorders, if any, which may cause 
serious genetic diseases, such as breast and ovarian cancers caused by the BRCA1 
gene. As a consequence, the people with genetic disorders lose an important 
opportunity to make their lifestyle change and to take regular medical examinations 
which detect cancer at an early stage and receive necessary medical treatment to 
save their lives. In this context, strong fears of genetic discrimination affect 
peoples' decisions to take genetic tests and therefore restrict peoples' right to know 
their own genetic information. 
  Indeed, to prevent the chilling effect of undergoing genetic tests is one of the 
main arguments to support legal prohibition an the insurers' use of genetic 
information in the insurance underwriting process.
B. Model Genetic Privacy Act of 1995
  In the USA, one of the initial models in drafting current genetic privacy and 
genetic anti-discrimination legislations is the model Genetic Privacy Act of 1995 
(Hereinafter MGPA).33) MGPA was a proposal for federal egislation. Originally, 
it was drafted as a federal statute to provide uniformity across state lines. However, 
the Act also has been used as guidelines by individual states.34) 
  MGPA was designed to protect individual genetic privacy while permitting 
medical uses of genetic analysis, legitimate research in genetics, and genetic 
analysis for identification purposes.35) Therefore, the main goal of MGPA is to 
balance these important interests at stake. MGPA is thoughtfully and 
comprehensively drafted and defines many terms, followed by a detailed
33) George J. Annas, Leonard H. Glantz & Patricia A. Roche, Genetic Privacy Act and Commentary. 
   The model Genetic Privacy Act of 1995 is the final report of a project entitled "Guidelines for 
   Protecting Privacy of Information Stored in Genetic Data Banks" which was funded by the 
   Ethical, Legal & Social Implications of the Human Genome Project, Office of Energy Research, 
   U.S. Department of Energy, No. DE-FG02-93ER61626. This act and commentary is available at 
      <http://www.ornl.gov/TechResources/Human Ge ome/resource/privacy/privacyl.html> (last
  visited July 12, 2001). 
34) Id. at 5. 
35) Id. at 5-6.
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commentary. 
  George J. Annas, one of the drafters of MGPA, summarizes the core provisions 
of the Act: 
      No collection of DNA for analysis is permissible without an informed 
   voluntary authorization by the individual or his or her legal 
    representative. 
      Those conducting DNA analysis are prohibited from doing so unless 
   execution of written authorization by the individual or legal 
    representation has been verified. 
      No analysis may exceed the scope of the written authorization. 
     DNA is the property of the individual from whom it is obtained. 
      DNA samples must be routinely destroyed once the authorized 
   analysis has been completed. 
      Anyone who holds private genetic information in the ordinary course 
   of business must keep such information confidential and is prohibited 
   from disclosing it unless the disclosure has been authorized in writing by 
   the individual or legal representative."36)
  Here, it is useful to observe the objectives of the bill for the purpose of this 
paper. Mark A. Rothstein suggests eight key policy goals "underlying any effort to 
protect privacy and confidentiality of genetic information. 
    (1) preventing at-risk individuals whowant to undergo genetic testing 
       from being dissuaded from doing so because of a fear that the 
       information generated by the tests may be used to their detriment;
(2) 
(3)
(4)
(5)
preventing individuals from being coerced into genetic testing; 
preventing individuals untrained in genetics, both laypeople and 
health professionals, from making decisions based an genetic 
information, which they may misinterpret; 
conserving medical resources by preventing genetics professionals 
and medical technologies from being used for inappropriate 
nonmedical purposes; 
preserving the quality of genetic testing and counseling by limiting 
their use in nonclinical settings, where testing may not be of the best 
quality and counseling may not be provided;
36) George J. Annas, Genetic Privacy: There Ought to be a Law, 4 TEx. REV. L. & POL. 9, 14-15 
  (1999).
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(6)
(7) 
(8)
conserving human resources by not disqualifying individuals from 
current activities (such as employment) because of a fear of future 
illness; 
preventing discrimination based an genetic information; 
preventing enetic reductionism and determinism, in which genetic 
explanations for health and behavior are predominant factors in 
evaluating various aspects of human affairs.37)
C. Interests at Stake in Legal Policy over Genetic Privacy Protection
  When we explore into an adequate legal policy for protecting genetic privacy 
and preventing genetic discrimination, what kind of competing interests are at 
stake? In this section, 1 will consider interests which would be the basic factors to 
seek an adequate legal policy over privacy protection by referring to the argument 
delivered by leading scholars in this field. 
  Lawrence 0. Gostin and James G. Hodge, Jr. address the interests at issue over 
genetic privacy. They argue that the key issue lies in how to reconcile genetic 
information privacy and collective benefits. They point out several public 
collective benefits of genetic information: (1) Enhanced Patient Choice; informed 
individual choices by giving individuals predictive information about their health 
Status: (2) Clinical Benefits: identification of the etiology and physiology of 
disease; (3) Improved Research: clinical advances to treat genetic diseases; (4) 
Protection of Public Health: improved public health protection through the use of 
genetic information to track the incidence, patterns, and trends of genetic carrier 
states or diseases across populations, thus leading to more effective, targeted 
prevention.38) 
  Gostin and Hodge present a series of recommendations which reconcile 
collective benefits of genetic information and privacy risks such as discrimination 
or stigmatization, etc. According to them, by following these recommendations, 
legislation can achieve a "carefully crafted balance that manages to respect 
individual privacy and provide security protections without significantly thwarting 
the warranted, communal uses of genetic information."39) Their recommendation is 
what they call "fair information practices or principles" which consist of (a)
37) Mark A. Rothstein, Recommendations: Genetic Secrets: A Policy Framework, at 451-52. 
38) Lawrence 0. Gostin & James G. Hodge, Jr., Genetic Privacy and the Law: An End To Genetics 
   Exceptionalisni, 40 JURIMETRICS J. 21, 22, 37-39 (1999). 
39) Id. at 53.
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Substantive Review; (b) Procedural Review; (c) Control of Personal Health Data; 
(d) Right to Review and Correct Personal Data; and (e) Use of Data for Intended 
Purpose. According to Gostin and Hodge, Fair Information Practices mean 
"fundamental legal and ethical principles concerning individual privacy and 
information collection that underlie the acquisition, use, and disclosure of 
identifiable health information."40) Here, let us take a look at each concept in detail 
respectively. 
  (a) Substantive Review: One of the fair information principles is substantive 
review which imposes a burden an the collector of health data "to assert a 
substantial public interest" and "to demonstrate hat it would be achieved." Gostin 
and Hodge state as follows. 
    Information should only be collected when the need for the information 
    is substantial, the collection of the data would actuallyachieve the 
    objective, the purpose could not be achieved without the collectionof 
    identifiable information, and the data would be held only for a period 
    necessary to meet the valid objectives.41) 
  (b) Procedural Review: Gostin and Hodge state that procedural review also 
should be required in collecting health information: "[D]ecisions to create health 
databases . . . ought to require procedural review. Some mechanism for 
independent review by a dispassionate, xpert body would provide a forum for 
careful examination of the justification for the collection of data, the existence of 
thoughtful consent procedures, and the maintenance of adequate privacy and 
security."42) 
  (c) Control of Personal Health Data: Moreover, fair information principles 
require that "individuals about whom data are collected must be afforded the right 
to know about and, to a meaningful extent, control the uses of those data."43) In 
other words, it should be guaranteed that "individuals have a legitimate claim to 
information about: (1) how privacy and security will be maintained; (2) how to 
access and review records; (3) the length of time that the information will be stored 
and the circumstances under which it would be expunged; (4) third parties who are 
authorized access to the data; and (5) future secondary uses."44) 
  (d) Right to Review and Correct Personal Data: Fair information principles also
40) Id. at 54. 
41) Id. (emphases added). 
42) Id. at 54-55 (emphasis added). 
43) Id. at 55. 
44) Id.
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require that "individuals have the right to see data about themselves and to amend 
inaccurate or incomplete record. This right respects a person's autonomy and better 
assures the accuracy of data."45) And an individual "must be fully informed about 
the content and meaning of any genetic analysis-past, current, or future."46) 
Therefore, "[i]f the tissue [collected and stored] were used in the future to predict 
an unrelated condition in the donor, she would have to consent and would have to 
access to any new information derived from that particular genetic analysis."47) 
  (e) Use of Data for Intended Purpose: Finally fair information principles require 
that possessors of genetic information of somebody eise "have an obligation to (1) 
use health information only for limited purposes, (2) disclose information only for 
purposes compatible with the purpose for which the data were obtained, (3) curtail 
disclosure to the minimum necessity to accomplish the purpose, and (4) account for 
any disclosures."48)
  Madison Powers also examined competing interests that need to be taken into 
account in formulating acomprehensive genetic privacy protection policy.49) 
  According to Powers, in the traditional picture, "individual interests widely cited 
an behalf of privacy protection policies are contrasted with various social interests 
in making more information readily accessible to other individuals or institutions 
for the Bake of public good."50) Powers identifies four general headings that 
classify interests that individuals have in genetic privacy protection: (1) the 
protection of individuals' social and economic well-being; (2) psychological 
interests; (3) relational interests; and (4) autonomy.51) 
  The First heading that Powers suggests is the protection of individuals' "social 
and economic well-being." If there is no restriction an gaining access to genetic 
information of the individual by a third party, it may create "social stigma and 
discrimination" against that person and cause "adverse social and economic 
consequence such as the loss of employment opportunity and insurability."52)
45) Id. 
46) Id. 
47) Id.. 
48) Id. at 56. 
49) Madison Powers, Justice and Genetics: Privacy Protection and the Moral Basis of Public Policy, 
   in GENETIC SECRETS: PROTECTING PRIVACY AND CONFIDENTIALITY IN THE GENETIC ERA 355 (Mark A . 
   Rothstein ed., Yale Univ. Press 1997). 
50) Id. at 356. 
51) Id. at 357-59. 
52) Id. at 357.
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  The second interest individuals may have in any genetic privacy policy choice 
that Powers observes is the "individual's psychological interests." The 
dissemination of genetic information to others "may result in severe emotional 
distress due, for example, to the perception of social Stigma or loss of respect by 
others."53) The disclosure of genetic information may create "significant adverse 
consequences for social standing and Sense of self-worth"54) and "profoundly affect 
an individual's very self-concept and capacity for functioning in society."55) 
  The third interest at stake is what he calls "relational interests." He notes that 
"[w]hen genetic information obtained from one patient or subject is revealed to 
other family members"56) without his/her informed consent, "the ability of persons 
to shape their most intimate relationship is compromised, and the trust and patterns 
of usual communication within families can be compromised."57) 
  The fourth interest at stake is "autonomy." Powers states that "[a] crosscutting 
set of genetic privacy interests comprises the interests individuals have in the 
protection of their autonomy."58) He asserts that "the ability to make a variety of 
medical and other personal choices without substantial interference by others often 
depends an the protection of informational privacy."59) This is because if "learning 
one's own genetic Status creates legal duties or economic pressure to make such 
information available to employers or insurers, then an individual's autonomy 
within both medical and nonmedical spheres of life may be undermined."6o) 
  Another example that Powers gives as undermining interests of autonomy is the 
adverse affect an one's reproductive freedom. Powers maintains that "a decision to 
have children who may develop heritable medical conditions may cause their 
employer to impose limits an the insurance coverage available to their families."61) 
Therefore, Powers asserts that "[t]he lack of assurances that privacy will be 
protected also may deter persons from seeking beneficial medical testing and 
treatment for themselves."62) This chilling effect that makes people hesitate or 
refrain from taking beneficial medical testing and treatment is not likely to be
53) Id. at 358. 
54) Id. 
55) Id. 
56) Id. 
57) Id. 
58) Id. 
59) Id. at 359. 
60) Id. 
61) Id. 
62) Id.
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apparent compared to adverse conomic onsequence but is a very important factor 
that should be taken into consideration when examining the genetic privacy and 
discrimination issues in the insurance and employment settings. 
  The next question is to identify competing social interests that conflict with 
these individual interests at stake in privacy protection. Powers observes (1) the 
promotion of scientific research; (2) public health or safety; and (3) economic 
efficiency. 
  Powers states that if "the genetic screening to track the incidence of genetic 
conditions ... or carrier status is used to provide individuals with information that 
they can use to enhance patient choice or improve patient outcomes for themselves 
or their children," the benefit society gets as a whole "can be considerable."63) He 
maintains that "[s]ome researchers worry that stringent privacy protection policies 
can have the undesirable effect of reducing the available data crucial for 
research."64) 
  However, Powers also observes that there is a situation in which, between 
individual interest and social interest, "potentially conflicting interests can be 
harmonized" because not only society as a whole, but also "individual patients 
ultimately stand to benefit from public policies that ensure that genetic information 
is made available for research purpose."65) He notes: 
    Research conducted as a result of access to data obtained from both 
    population screening and individualized genetic testing may provide the 
    knowledge basis needed for enhanced patient decision making. 
    Knowledge of genetic susceptibilities may allow patients to make more 
    informed decisions about examinations, diet, behavior, and exposures to 
    environmental hazards. Individuals may benefit from the knowledge 
    gained from genetic research in making such reproductivedecisions as 
    preconception planning, preimplantation diagnosis, or deciding whether 
    to terminate apregnancy.66) 
  Hence, making genetic data more readily available to medical researchers will 
develop new Eindings and knowledge about genetics, and enhance the possibility of 
medical treatment to cure or prevent genetic diseases. 
  1 call this argument a "paternalistic argument" for restricting genetic privacy 
because the core logic of this argument is that permitting access to an individual's
63) Id. at 360. 
64) Id. 
65) Id. 
66) Id. at 360.
90 OSAKA UNIVERSITYLAWREVIEW [No. 52: 75
genetic information by a researcher ultimately results in benefiting that person in 
the Jong run. However, it is sometimes dubious whether the person whose genetic 
information was accessed would be the person who would receive the benefit 
because normally there is a time lag in getting the benefit from the research. Also 
the benefit from the advancement of genetic research will be shared by all members 
of the society. Therefore, it may have a similar structure as in the Situation of 
taking property by the government which requires just compensation, if genetic 
information can be regarded as a property right. 
  Other social interests that Powers observes are "public health or safety" and 
"economic efficiency." He gives an example in the workplace and states that 
"[e]mployers may be able to decrease workplace hazard abatement cost and reduce 
their financial liability from tort litigation or workers' compensation for work-
related illnesses through selective hiring and placement practices, or reduce the 
costs of health insurance benefits for their employees by eliminating medically 
costly employees and reducing available employee health insurance coverage for 
certain conditions."67) However, Powers asserts that "it is an open question 
whether important societal interests, such as the promotion of public health or 
economic efficiency, are arrayed an the side of increasing, rather than restricting, 
access to genetic information."68) 
  Powers suggests a pragmatic approach to privacy policy. Here it seems to be 
useful in balancing these various competing interests by referring to his pragmatic 
approach argument. He asserts that "a pragmatic approach to privacy protection 
will be required to accommodate he diverse set of interests at stake in a variety of 
research, clinical, and administrative context."69) According to him, essential to the 
pragmatic approach is the following recognition. 
   [A] recognition that the kindsof information that ought to be protected 
    from access, the degree and nature of the protection needed,and the 
    institutional arrangements hat determine the contingent importanceof 
   privacy will vary, depending upon the kinds of harms threatened by a 
   loss of privacy and the vulnerabilities of persons under any given set of
    economic and social arrangements.70) 
  According to Powers,there are at least two types of policy options which are 
available for the policy maker:
67) Id. at 361. 
68) Id.. 
69) Id. at 362. 
70) Id.
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    Either access to genetic information may be prohibited or restricted 
   through the creation and enforcement of a System of legal rights and 
    duties, or the institutional arrangements hemselves may be changed, 
    such that incentives for some to gain access to genetic information to the 
    detriment of others are reduced or eliminated.71) 
  The first policy option, what he calls "the traditional privacy policy approach," 
is "the creation and enforcement of legal right" and "[t]he most stringent ypes of 
privacy rights are rights of informational self-determination."72) Under this 
approach, "the only feasible way of protecting the interests that give rise to privacy 
concerns is to create a right to control what information is generated or a right to 
control subsequent disclosure of, or uses for, information once it is generated and 
revealed to designated persons for specific purposes."73) 
  Another Option that the policy maker has for protecting genetic privacy is 
"reconfiguring" or making "substantial modifications of existing institutional 
arrangement."74) He asserts that "[r]ather than achieving the goal of reducing 
access to genetic information through a System of legally enforceable rights, the 
same desired effect may be achieved by making access to such information 
economically worthless."75) One example of the measures of the genetic privacy 
protection policy by institutional reform that Powers mentions is a "health care 
financing policy that eliminates the market incentives for gaining access to genetic 
information."76) 
  According to him, the choice between these two different alternatives (creating 
new legally enforceable rights of privacy or adopting institutional reform) is 
dependent an the following considerations. 
    [I]f laws restricting employer access to genetic information reasonably 
   require exceptions that allow employer access for purposes other than the 
   determination of insurance eligibility or coverage decisions, then 
   restrictions may be difficult to enforce or easily circumvented. If the 
   financial viability of insurance plans offered by employers or other 
    insurers depends an access to information about medical risks generally, 
   prohibition of one type of risk-related information may not produce an
71) Id. at 363. 
72) Id. 
73) Id. 
74) Id. at 363-35. 
75) Id. at 365. 
76) Id.
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    economically stable environment adequate to guarantee solvency and 
   continuity of health insurance. In light of such considerations, policy 
   makers must take seriously the possibility that the most feasible 
    alternative for protecting the interests at stake may be the elimination of 
    a risk-based insurance scheme.77) 
  However, Powers did not address any specific answer to the question in regards 
to what extent legal protection policy over genetic privacy should be required or to 
what degree the access to genetic information by employer or insurance company 
or researcher or family members should be limited. This is because he observes 
that "[t]he variety of interests at stake and complexity of the patterns in which those 
interests intersect make uniformly applicable solutions impossible."78) Therefore, 
there is "no single answer to the protection of the interests put at risk by the 
increased access some persons and institutions have to genetic information."79) 
However, he goes an to state that "the pragmatic approach does provide useful 
guidelines for policy makers."80) Then, what is this guideline? He asserts: 
    When other alternatives for privacy protection are unreliable, the 
    underlying interests of the individual are substantial, and the interestsat 
   stake include important aspects of individual autonomy, individual rights 
    of control, both the generation and subsequent disclosure of genetic 
    information, may be the only feasible policy alternative. In othercases, 
    the best vehicle for protecting the interests underlying our concerns 
    about genetic privacy may require changes in the economic and social 
    institutions themselves.81) 
  His pragmatic approach to privacy policy does not suggest any specific 
prescription for the policy maker although it suggests a rough guideline in regards 
to the interests at stake when the policy maker considers an adequate balancing of 
interests and solves the privacy protection issue. However, his argument shows 
how difficult it is to reach an appropriate policy over the genetic privacy issue, and 
he appropriately points out that "[f]undamental issues of justice lie at the core of 
any policy meant o ensure the protection of genetic privacy."82) When he mentions 
"fundamental issues of justice
," he stresses especially "distributive justice and the
77) Id. at 364-65. 
78) Id. at 366. 
79) Id. 
80) Id. 
81) Id. at 366-67. 
82) Id. at 367.
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role of the state in affecting patterns of distribution within society."83) As Powers 
points out, there is the fundamental question of political philosophy. Behind the 
arguments and debates over the legal policies of the genetic discrimination issues in 
insurance and employment, there is a fundamental theoretical conflict over 
distributive justice and fairness. To identify the theoretical conflict is beyond the 
scope of this paper, although this issue has been discussed in my original thesis. 
Here, it is important o confirm that it is indispensable to consider the underlying 
legal and political philosophy in examining an appropriate legal policy for genetic 
privacy and genetic discrimination. 
  In sum, it is important to confirm the following insights that 1 have 
demonstrated. As the main goal of the model Genetic Privacy Act and also as the 
arguments presented by commentators have demonstrated, the key issue is how to 
balance and reconcile the interests of individual genetic privacy and the interests of 
promotion of scientific research and public health or safety. And as has been 
pointed out, genetic discrimination undermines not only the genetic privacy of the 
people who are discriminated against but also hinders further development of 
genetic research and public health. Accordingly, preventing enetic discrimination 
is one of the prime social agenda of most importance in the twenty-first century. 
Therefore, legal protections against genetic discrimination are indispensable in 
order to prevent creating a "genetic underclass," to preserve the "right to know" and 
"right not to know" of our own genetic information
, to eliminate fear which 
discourages people undergoing genetic tests or participating in genetic research, 
and as its result, to develop medicine and biology, and ultimately enhance public 
health by curing and preventing enetic diseases which will lead to cutting overall 
health care costs. 
  As we have seen, the above examination explains the compelling individual and 
public need to prevent genetic discrimination and to protect genetic privacy legally. 
However, in order to explore an appropriate legal policy for the genetic 
discrimination issues, it is also necessary to ask what the nature of genetic 
information is. In the next section I will examine the so called "Genetic 
Exceptionalism."
III. Nature of Genetic Information
The main purpose of this section is to identify the nature and character of
83) Id. at 366.
94 OSAKA UNIVERSITY LAW REVIEW [No. 52: 75
genetic information by reviewing the arguments of "genetic exceptionalism."84) 
  In the Introduction of the model Genetic Privacy Act of 1995, it is stated that 
"[t]he Act is based an the premise that genetic information is different from other 
typen of personal information in ways that require special protection."85) Virtually 
all the genetic privacy laws or genetic anti-discrimination statutes and their 
proponent arguments which assert hat genetic privacy requires special protection 
by law presuppose that genetic information is unique and different from other kinds 
of personal information. Therefore, one important angle to evaluate legal policy 
protecting enetic privacy such as the genetic-specific anti-discrimination laws lies 
in exploring the question of "what is genetic information?"
A. Genetic Exceptionalism
  What makes genetic information different from other medical information? 
George J. Annas, Leonard H. Glantz, and Patricia A. Roche, drafters of the model 
Genetic Privacy Act of 1995, assert in the Introduction of the Act that "[g]enetic 
information is powerful and personal. As the genetic code is deciphered, genetic 
analysis of DNA will teil us more and more about a person's likely future, 
particularly in terms of physical and mental well-being."86) They go an to state: 
    Genetic information is uniquely sensitive . . . [because] [f]irst ... the
84) See, e.g., Thomas H. Murray, Genetic Exceptionalism and "Future Diary": Is Genetic 
   Information Different from Other Medical Information?, in GENETIC SECRETS: PROTECTING PRIVACY 
   AND CONFIDENTIALITY IN THE GENETIC ERA 60 (Mark A. Rothstein ed., Yale Univ. Press 1997); 
   Lawrence O. Gostin & James G. Hodge Jr., Genetic Privacy and the Law: An End to Genetics 
   Exceptionalism, 40 JURIMETRICS J. 21 (1999); Zita Lazzarini, What Lessons Can We Learn From 
   the Exceptionalism Debate (Finally)?, 29 J.L. MED. & ETHICS 149 (2001); Glenn McGee, 
   Foreward: Genetic Exceptionalism, 11 HARV. J.L. & TECH. 565 (1998); Lainie Friedman Ross, 
   Genetic Exceptionalism vs. Paradigm Shift.• Lessons From HIV, 29 J.L. Med. & Ethics 141 
   (2001); Natalie E. Zindorf, Comment, Discrimination in the 21st Century: Protecting the Privacy 
   of Genetic Information in Employment and Insurance, 36 TULSA L.J. 703, (2001); Jennifer S. 
   Geetter, Coding for Change: The Power of the Human Genome to Transform the American 
   Health Insurance System, 28 AM. J.L. & MED. 1 (2002). 
85) George J. Annas, Leonard H. Glantz, & Patricia A. Roche, Genetic Privacy Act and Commentary 
   (1995) available at <http://www.ornl.gov/TechResources/Human_Genome/resource/privacy/ 
   privacyl.html> (last visited Nov. 17, 2000); also available at <http:// www.ornl.gov/hgmis/ 
   resource/privacy/privacyl.html>(last vi ited June 17, 2002). Also see George J. Annas, Leonard 
   H. Glantz & Patricia A. Roche, Drqfting the Genetic Privacy Act: Science, Policy, and Practical 
   Considerations, 23 n4 J. L. MED & ETHIcs 360 (1995); Patricia Roche et al., The Genetic Privacy 
   Act: A Proposal for National Legislation, 37 JURIMETRICS J. 1 (1996). 
86) Patricia Roche et al., The Genetic Privacy Act: A Proposal for National Legislation, 1.
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    information in the genetic code is largely unknown to the person in 
    whose genetic material it is found. Therefore, if this informationis 
    obtained by someone else without the individual's permission, another 
   person would learn intimate details of the individual's likely future life. 
    A stranger could, in effect, read the future diary of an individual without 
    even knowing that the diary exists. . . . Second, deciphering an 
    individual's genetic code also provides the reader of that code with 
   probabilistic health information about hat individual's family, especially 
    parents, siblings and children. Third, since the DNA molecule is stable, 
    once removed from a person's body and stored, it can become thesource 
    of an increasing amount of information as more is learned about how to 
   read the genetic code. Finally, genetic information (and misinformation) 
    has been used by governments to viciously discriminate against those 
   perceived as genetically unfit.87) 
  Annas strongly asserts that "genetic information is uniquely private and should 
be protected by law."88) Therefore, it is required to treat genetic information 
differently and give special egal protection to genetic information.
  Thomas H. Murray labeled these arguments "Genetic Exceptionalism."89) 
According to Murray, Genetic Exceptionalism means "the claim that genetic 
information is sufficiently different from other kinds of health-related information 
that it deserves special protection or other exceptional measures."90) Murray 
observes three bases of genetic exceptionalism: (1) concern about genetic prophecy; 
(2) concern for kin; and (3) concem about genetic discrimination. 
  (1) Genetic prophecy: The reason why it is named "prophecy" is that genetic 
information is regarded as a "future diary."91)
87) Id. 
88) George J. Annas, Genetic Privacy: There Ought to be a Law, 4 Tex. Rev. L. & Pol. 9, 13 (1999) 
   (Technological Innovation & Legal Tradition: Enduring Principles For Changing Times, The 
   Federalist Society 1998 National Lawyers Convention). 
89) Thomas H. Murray, Genetic Exceptionalism and "Future Diary ": Is Genetic Information 
   Different from Other Medical Information? in GENETIC SECRETS: PROTECTING PRIVACY AND 
   CONFIDENTIALITY IN THE GENETIC ERA, 60, 61 (Mark A. Rothstein ed., Yale Univ..Press 1997). 
   Murray was the chair of the Task Force an Genetic Information and Insurance of the NIH-DOE 
   Joint Working Group an Ethical, Legal, and Social Implications of the Human Genome Project. 
   And this Task Force used the term "Genetic Exceptionalism" in the above meaning. 
90) Id. 
91) Id. at 62. Murray borrows this phrase from Nancy Wexler.
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    Genetic information "can predict an individual's likely medical future 
    for a variety of conditions." ... DNA [][is] a "coded probabilisticfuture 
    diary because it describes an important part of a person's unique future 
    and, as such, can affect and undermine an individual's view of his/her 
    life possibilities. Unlike ordinary diaries that are created by thewriter, 
    the information contained in one's DNA, which is stable and can be 
    stored for long periods of time, is in code and is largely unknown to the 
    person. Most of the code cannot now be broken, but parts are being 
    deciphered almost daily."92) 
  (2) Concern for Kin: Genetic information "`divulges personal information about 
one's parents, siblings, and children. "'93) "Genetic information about each of us, 
then, is also to some extent information about our ancestors, descendants, and other 
such biological relations as sisters and brothers."94) 
  (3) Concern about Genetic Discrimination: This was derived from "a fear of 
discrimination" by looking back at the history of eugenics which stigmatized and 
victimized people.95)
  Roger B. Dworkin also points out the differences between gene information and 
other medical information.96) 
   Geneticinformation is different from other kinds of medical information 
   because although most medical information about a person'shealth tells 
    us nothing about anybody else's health, learning about one person's 
    genetic makeup often requires leaming about someone lse, and gaining 
   genetic information about one person inevitably reveals information 
    about others.... Genetic information is family information. People seek 
   genetic advice because of concerns about conditions that exist in their 
   family; once learned, the information is relevant o many members and 
   potential members of the family . . . [for example] the diagnosisof a 
   child with a genetic disease reveals information about the child's parents
92) Id. at 62 (quoting George J. Annas, Leonard H. Glantz & Patricia A. Roche, Drafting the Genetic 
   Privacy Acta Science, Policy, and Practical Considerations, 23n4 J. L. MED & ETHtcs360, 360 
  (1995)). 
93) Id. (quoting Annas, Glantz & Roche, Drafting the Genetic Privacy Act: Science, Policy, and 
   Practical Considerations, at 365). 
94) Id. at 62, 65. 
95) Id. 
96) ROGER B. DWORKIN, LIMITS: THE ROLE OF THE LAW IN BIOETHICAL DECISION MAKING (Indiana Univ. 
  Press 1996).
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and the parents' relatives that may be relevant to those persons' 
reproductive decision making; the diagnosis of a person with a genetic 
disease reveals information about that person's relatives that may be 
relevant to their own health; genetic testing to diagnose or confirm the 
diagnosis of a condition may reveal that a women's husband is not the 
parent of her child.97)
  Ronald M. Green and Mathew Thomas observe five distinguishing features 
which make DNA-derived information different from ordinary confidential medical 
information: (1) informational risk; (2) the longevity of DNA; (3) DNA as an 
identifier; (4) familial risks; (5) and community impacts.98
B. Critical Review of Genetic Exceptionalism
  Murray gives an objection against genetic exceptionalism. According to him, 
the reasons which support genetic exceptionalism are also true of other medical 
information. He notes that "[g]enetic information is neither unique nor distinct in 
its ability to offer probabilistic peeks into our future health. Many other things 
afford equally interesting predictions."99) For example, "asymptomatic hepatitis B 
infection, early HIV infection, and even one's cholesterol evel" also "have 
implications for future health that are every bit as cogent and sensitive as genetic 
predispositions."100) Consequently, "genetic prophecy" argument is not compelling. 
  He also doubts the argument appealing to "concern about kin." He notes: "That 
one member of a family has tuberculosis is certainly relevant to the rest of the 
household, all of whom are in danger of infection .... Likewise, if one partner in a 
marriage has a sexually transmitted isease, that information is important for the 
other partner."101) Accordingly, he asserts that "it is difficult to claim uniqueness, 
or even special importance and sensitivity, for genetic information."102) 
  Based an the same reason, Murray criticizes the argument appealing to "concern 
about genetic discrimination" as a basis for genetic exceptionalism. He argues that
97) Id. at 94 
98) Ronald M. Green & Mathew Thomas, DNA: Five Distinguishing Features for Policy Analysis, 11 
   HARV. J. LAW & TECH. 571 (1998). 
99) Murray, supra note 414, at 64. 
100) Id. at 64. 
101) Id. at 65. 
102) Id.
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    insurers use evidence of current disease or future disease risk-whether 
    it is genetic or nongenetic doesn't matter-to decide who gets a policy, 
    what that policy covers, and how much it costs. Whether this 
    discrimination should be regarded as fair or unfair is debated. But it is 
    difficult to make the argument that it is fair to discriminate an nongenetic 
    factors but unfair to discriminate an genetic ones."103) 
  However, in my view, some of the counter-arguments would seem to have 
misinterpreted the point of the unique character of genetic information which 
Murray calls concern about kin. Genetic information can be unique and sensitive 
not in the Sense that it may harm one's family who have not yet undergone genetic 
tests, both physically and economically by incurring financial damage associated 
with unemployment or losing insurance or even death of the breadwinner who 
underwent genetic tests and was found to have genetic defects, or by infecting 
family members with a contagious disease. But rather it can be unique in the sense 
that genetic information of a family member may also disclose the rest of the family 
members' genetic profiles or increase the possibility of their having the same 
genetic defects, and therefore social stigmatization and discrimination for the rest of 
the family members would more likely happen than in the case of other non-genetic 
medical information. 
  One reason Murray tries to reject genetic exceptionalism is to avoid genetic 
reductionalism or genetic determinism.104) He is afraid that genetic exceptionalism 
would lead to such reductionalism or determinism. Genetic determinism will not be 
discussed in this paper but 1 would like to confirm the following matter. Either 
identifying the uniqueness or sensitiveness of genetic information or giving special 
protection to genetic information does not necessarily commit to genetic 
reductionalism or genetic determinism. It means at most, genetic exceptionalism. 
In my view, one difference between genetic exceptionalism and genetic 
reductionalism or genetic determinism is that the former implies that genetic 
information is unique and has its own special nature but the latter rejects 
environmental factors which cause genetic diseases and regards human beings as 
the sum of our genes. Undoubtedly, genetic exceptionalism does not go as far as to 
assert to that extent. As we have seen, Murray does not support genetic 
exceptionalism. He concludes that genetic information does "not differ 
substantially from other kinds of health-related information."los)
103) Id. 
104) Id. at 69-72. 
105) Id. at 61.
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  When we consider the nature and features of genetic information, it is important 
to take the different ypes of genetic diseases into account. In regards to this, it is 
useful to understand ifferent ypes of genetic anomalies which can cause many 
diseases. Eric Mills Holmes classifies them into four different ypes. 
   (1) Monogenic or single gene disorders. Some diseasesmay be caused by 
    one improperly functioning gene...This type of disorder is characterized 
   by a pattern of transmission in a family. If an abnormality is evident when 
    only one of the chromosomal pair contains the variant gene, the disorder 
    is termed a dominant single gene order.... If the disease manifests itself 
   only when both of the chromosomal pair possess the variant gene, it is 
   termed a recessive single gene disorder. The recessive disorder occurs 
   when an affected person inherits a mutant gene from each parent, often 
    even though neither parent has the disease.... Common examples are 
    sickle-cell anemia ... and cystic fibrosis ... [and] there are about 3600 
   different identified disorders. 106) 
   (2) Chromosomal disorders. Other diseases result from visible 
    aberrations in chromosome structure or number[] . . . These disorders 
   account for a significant percentage of birth defects, mental retardation, 
    and miscarriages.... Disease results because there is either a missing or 
    an extra chromosome which results in physical or mental 
   maldevelopment." These disorders account for a significant percentage of 
   birth defects, mental retardation, and miscarriage. [e.g. Down's 
   syndrome] 107) 
   (3) Multifactorial disorders.... these disorders result from the interaction 
   of environmental factors and many abnormal genes presumably an 
   different chromosomes. Examples include asthma, epilepsy, coronary 
   heart disease, diabetes mellitus, multiple sclerosis, schizophrenia, some 
   sort of arthritis and emphysema. 108) 
   (4) Non-Inherited disorders: [These are diseases] resulting from genetic 
   changes occurring during one's life that are not inherited disorders. 
    ...This change can happen when genes are damaged or if extemal factors
106) Eric Mills Holmes, Solving the Insurance/Genetic Fair/Unfair Discrimination Dilemma in Light 
    of the Human Genome Project, 85 Ky. L.J. 503, 527-28 (1996-97). His description of thefour 
    classifications of genetically-caused isease is based an the Ohio Task Force an Genetic 
    Testing, Final Report (Dec. 31, 1995) at 3-4. 
107) Id. at 528. 
108) Id.
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    (such as chemicals, radiation, viruses, or cigarette smoking) alter the 
     genetic structure of cells. Most cancers are examples.109) 
   As these classifications indicate, when we mention "genetic disorder" or 
"genetic disease
," its implication differs widely depending an what kind of "genetic 
disorder" or "genetic disease" we have in mind. For example, if we talk about 
monogenic or single gene disorders such as Huntington's disease, sickle-cell 
anemia, and cystic fibrosis, etc., it is certain that they are very different from other 
diseases which have been traditionally seen as non-genetic diseases because the 
environmental or lifestyle factors play little role to develop or manifest these 
monogenic diseases. However, the difference between these types of genetic 
diseases and HIV are smaller than the difference between HIV and other medical 
information in that both carriers of HIV and genetic diseases caused by a single 
disorder will surely develop diseases at an unknown future time and after their 
manifestations, it is difficult to cure these diseases by using present medical 
techniques. On the order hand, genetic diseases caused by multi-factorial genetic 
disorders have very similar characters with diseases uch as heart disease, diabetes, 
etc., that we have traditionally regarded as non-genetic diseases. These kinds of 
genetic diseases are different from HIV or other infectious diseases such as 
Hepatitis C virus, etc. Accordingly, we can say that the features of some types of 
genetic diseases overlap with other traditionally seen non-genetic diseases and 
some do not. And it is also important to note that most of the diseases are caused 
by complicated interaction between genetic factors and non-genetic factors such as 
environmental exposure or lifestyle but the degree of each factor's contribution 
varies widely disease by disease. Confusion which stems from this complicated 
nature of the disease onset causation seem to be one reason that genetic information 
is difficult to define. 
  Although,there are controversial debates over the issue of whether or not 
genetic information is different from other medical information, all observe a 
certain uniqueness of genetic information. However, when discussing genetic 
information as a social issue, not as a biological one, the issue we have to discuss is 
not the question of whether or not genetic information and other medical 
information are substantially different from each other but the question of whether 
a line can be drawn between them in drafting and enforcing law and whether the 
law ought to treat them differently or not. However, unfortunately, there is no 
space to address the details of these issues here, although they have been discussed
109) Id. at 528-29.
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in my original thesis.
Vl. Conclusion
   More and more people will have an awareness that the Human Genome Project 
has already opened the door of Pandora's box and inside this box there is a book 
entitled "Genetic Secret of Our Lives" containing biological genetic information. 
In the twenty-first century, the advancement of genetic technology would seem to 
pose one of the most serious civil rights issues. In the twentieth century, race and 
gender have been the center of the dass of discrimination. There is no doubt that in 
this century genetic discrimination will be the most serious and widespread ass of 
discrimination in legal discourse. Under this understanding, this paper starts by 
clarifying the meaning and scope of "genetic privacy" which is the central concept 
for protection in the issues of genetic discrimination and 1 have noted that access to 
genetic information by insurance companies and employers put "informational 
privacy" in danger and the requesting of genetic tests as a condition to obtain 
insurance policy or final job offer infringes the "physical privacy" and "decisional 
privacy" of the people. Especially "decisional privacy" is exposed to being 
threatened by genetic discrimination. Requiring genetic tests undermines the right 
not to know one's own genetic information. Even though the law prohibits insurers 
and employers from performing mandatory genetic testing, if using genetic 
information in discriminatory decisions in the workplace and insurance 
underwriting is not banned by law, the people hesitate to undergo genetic tests due 
to fear of genetic discrimination. Hence, strong fears of genetic discrimination 
affect people's decisions not to take genetic tests and therefore restrict people's 
right to know their own genetic information. And then, 1 briefly described the 
model Genetic Privacy Act of 1995 and observed that reconciling the two 
competing interests; securing genetic privacy and social benefits such as the 
promotion of scientific research, public health or safety is the main goal of the Act. 
  Furthermore, 1delineated the detail of the competing interests that needto be 
balanced in formulating a genetic privacy protection policy and introduced fair 
information practices or principles presented by Gostin and Hodge as an analytical 
tool which reconciles the competing benefits at stake. However, I pointed out that 
the pragmatic approach which balances these competing interests cannot give a 
perfect guideline in exploring adequate legal protection to genetic privacy because 
there is the fundamental issue of justice or fairness that still needs to be answered. 
  The primary purpose of this part was to highlight the compellingreasons why
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genetic discrimination should be legally banned. And the insight which has been 
reached was that genetic discrimination undermines not only the genetic privacy of 
the people who are discriminated against but also hinders further development of 
genetic research and public health. 1 concluded by asserting that legal protections 
against genetic discrimination are indispensable in order to prevent creating a 
"genetic underclass
," to preserve the "right to know" and "right not to know" of our 
own genetic information, to eliminate fear which discourages people from 
undergoing genetic tests or participating in genetic research, and as a result, to 
develop medicine and biology, and ultimately enhance public health by curing and 
preventing genetic diseases which will lead to cutting overall health care costs. 
  In the final section the nature and character of genetic information has been 
examined by reviewing the arguments of "genetic exceptionalism." However, 1 
noted that the important matter in the light of establishing legal protection for 
genetic privacy is not in the question of whether genetic information has a unique 
character compared to other medical information. The question of whether we can 
distinguish genetic information from other kinds of medical information should be 
examined. This is because even though a certain unique character of genetic 
information can be identified, many commentators have pointed out that it is 
impossible to treat genetic information differently from other medical information 
based an practical reasons. The more genetic technology advances, the more 
practically impossible it will become to distinguish between the two and find where 
the line is to be drawn. Therefore, in order to protect genetic privacy appropriately, 
the law should also protect the privacy of all predictive medical information as well 
as the so-called genetic information. 
  More importantly, when enacting genetic-specific antidiscrimination law or 
genetic privacy law, it should be discussed as a fundamental question of whether it 
is fair and equal to protect only genetic privacy and prohibit only genetic 
discrimination while leaving the people with non-genetic diseases unprotected. 
  Although there is no space left to address these issues in detail in this paper at 
this time, 1 plan to publish it an another occasion in the near future' loh
110) Much space has been devoted to discuss these issues in my original thesis. The following is the 
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